XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.880
+0.020 (0.70%)
At close: Jun 6, 2025, 4:00 PM
2.900
+0.020 (0.69%)
After-hours: Jun 6, 2025, 4:04 PM EDT

XBiotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
---4.0118.3943.98
Upgrade
Other Revenue
-----0.02
Upgrade
Revenue
---4.0118.3944
Upgrade
Revenue Growth (YoY)
----78.20%-58.19%-
Upgrade
Cost of Revenue
---0.655.8234.55
Upgrade
Gross Profit
---3.3612.579.45
Upgrade
Selling, General & Admin
5.624.714.666.319.3918.2
Upgrade
Research & Development
39.5537.7632.8531.5428.279.53
Upgrade
Operating Expenses
45.1742.4737.5137.8537.6627.73
Upgrade
Operating Income
-45.17-42.47-37.51-34.49-25.08-18.28
Upgrade
Interest Expense
-0.7-0.81----
Upgrade
Interest & Investment Income
8.669.8110.423.820.472.46
Upgrade
Currency Exchange Gain (Loss)
-3.66-5.531.89-2.8-0.713.5
Upgrade
Other Non Operating Income (Expenses)
1.430.430.88-0.12-0.13-0.5
Upgrade
EBT Excluding Unusual Items
-39.44-38.56-24.31-33.59-25.46-12.83
Upgrade
Pretax Income
-39.44-38.56-24.31-33.59-25.46-12.83
Upgrade
Income Tax Expense
-0.03-0.030.24-0.69-8.04-1.61
Upgrade
Net Income
-39.41-38.53-24.56-32.9-17.41-11.22
Upgrade
Net Income to Common
-39.41-38.53-24.56-32.9-17.41-11.22
Upgrade
Shares Outstanding (Basic)
303030303031
Upgrade
Shares Outstanding (Diluted)
303030303031
Upgrade
Shares Change (YoY)
0.11%0.07%-0.00%1.32%-2.53%-33.45%
Upgrade
EPS (Basic)
-1.29-1.26-0.81-1.08-0.58-0.36
Upgrade
EPS (Diluted)
-1.29-1.26-0.81-1.08-0.58-0.36
Upgrade
Free Cash Flow
-31.62-32.27-19.09-15.4165.92-68.88
Upgrade
Free Cash Flow Per Share
-1.04-1.06-0.63-0.512.19-2.23
Upgrade
Gross Margin
---83.77%68.36%21.48%
Upgrade
Operating Margin
----860.10%-136.36%-41.54%
Upgrade
Profit Margin
----820.45%-94.67%-25.50%
Upgrade
Free Cash Flow Margin
----384.26%358.38%-156.55%
Upgrade
EBITDA
-43.41-40.73-35.77-31.88-22.43-16.04
Upgrade
EBITDA Margin
-----121.96%-36.45%
Upgrade
D&A For EBITDA
1.761.751.742.612.652.24
Upgrade
EBIT
-45.17-42.47-37.51-34.49-25.08-18.28
Upgrade
EBIT Margin
-----136.36%-41.54%
Upgrade
Revenue as Reported
---4.0118.3944
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q